Clinical Trial Update: Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial assesses adding pioglitazone to existing therapy versus placebo in Type 2 diabetes, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN